The p38 MAPK Inhibitor SB203580 Blocks Adenosine A₁ Receptor-Induced Attenuation of In Vivo Myocardial Stunning

Author： Yoshimura Yukihiro Kristo Gentian Keith Byron Jahania Salik Mentzer Robert Lasley Robert

ISSN： 0920-3206

Source： Cardiovascular Drugs and Therapy, Vol.18, Iss.6, 2004-11, pp. : 433-440

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

SB203580, a specific inhibitor of p38-MAPK pathway, is a new reversal agent of P-glycoprotein-mediated multidrug resistance

By Baranck M. Bohacova V. Kvackajova J. Hudecova S. Krizanova O. Breier A.

European Journal of Pharmaceutical Sciences, Vol. 14, Iss. 1, 2001-08 ,pp. : 29-36

Elsevier

Access to resources Recommend Favorite

Regulation of p42/p44 MAPK and p38 MAPK by the adenosine A 1 receptor in DDT 1 MF-2 cells

By Robinson A.J. Dickenson J.M.

European Journal of Pharmacology, Vol. 413, Iss. 2, 2001-02 ,pp. : 151-161

Elsevier

Access to resources Recommend Favorite

P38 mitogen-activated protein kinase inhibitor SB203580 has a bi-directional effect on iNOS expression and NO production

By Lahti A. Kankaanranta H. Moilanen E.

European Journal of Pharmacology, Vol. 454, Iss. 2, 2002-11 ,pp. : 115-123

Elsevier

Access to resources Recommend Favorite

Selectivity of SB203580, SB202190 and Other Commonly Used p38 Inhibitors: Profiling Against a Multi-Enzyme Panel

Letters in Drug Design & Discovery, Vol. 2, Iss. 7, 2005-11 ,pp. : 516-521

Bentham Science Publishers

Access to resources Recommend Favorite

Intrastriatal adenosine A 1 receptor antisense oligodeoxynucleotide blocks ethanol-induced motor incoordination

By Phan T.A. Gray A.M. Nyce J.W.

European Journal of Pharmacology, Vol. 323, Iss. 2, 1997-04 ,pp. : 5-7

Elsevier

Access to resources Recommend Favorite